The present triple-blind, randomized, placebo-controlled crossover trial aims to examine the safety and efficacy of four types of cannabis (i.e., high THC, low CBD; high CBD, low THC; equal ratio THC/CBD; and placebo) among 76 military veterans with treatment-resistant PTSD. Participants will be recruited from one study site, the Scottsdale Research Institute (Phoenix, AZ).